Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Biomarkers Summit

Innovations in stratified medicine

16th January to 17th January 2013, London, United Kingdom

Overview

Open/Close

SMi’s sixth Annual Biomarkers conference unites advances in biomarker use for drug discovery and development, alongside biomarkers for cancer.  This two-day meeting showcases the best new opportunities and strategies to accelerate go/no-go decision making in early and clinical development.

Key academic, government and industry figures cover topics encompassing:

  • Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors
  • Interactive panel discussion focusing on current developments in personalised medicine via biomarkers
  • Latest advancements in molecular diagnostics and multi-centre clinical imaging studies
  • New developments in pharmacogenetic and pharmacogenomic statistical study design
  • Future direction and initiatives for safety biomarkers
  • Maximise the cost-effectiveness of your companion diagnostic for end-users

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close